Interestingly, although many ferroptosis regulators such as GPX4, SLC7A11, and FTH1 are obviously increased in certain cancers compared with normal tissues, the treatments targeting these regulators might vary in effectiveness across different cancers 70. This evidence concerns the gene SLC7A11 and cancer.